Atlas Trials

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)

Clinical trial NCT02900937 · UNKNOWN

Trial details

NCT number
NCT02900937
Sponsor
Amaranth Medical Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Artery DiseaseMyocardial Ischemia
Start date
2016-10-01
Primary completion
2018-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.